Clinical Report: Rebuilding the Lacrimal Blueprint
Overview
This study highlights the critical role of autophagy in the development and function of lacrimal gland-like organoids derived from human embryonic stem cells. Pharmacological agents, particularly nicotinamide mononucleotide (NMN), show promise in restoring function in autophagy-deficient models, suggesting potential therapeutic avenues for dry eye disease.
Background
Dry eye disease (DED) is a prevalent condition characterized by inflammation and damage to the ocular surface, often linked to lacrimal gland dysfunction. Understanding the molecular mechanisms underlying lacrimal gland development is essential for developing targeted therapies. Recent findings emphasize the importance of autophagy in maintaining lacrimal gland health and function.
Data Highlights
No numerical data available in the source material.
Key Findings
- Autophagy is essential for the proper differentiation and function of lacrimal gland-like organoids.
- Genetic knockout of ATG5 led to reduced expression of key markers (CK5, CK19, AQP5, α-SMA) and impaired secretory function.
- Autophagy-deficient organoids exhibited signs of cellular stress, including protein aggregation and increased apoptosis.
- Nicotinamide mononucleotide (NMN) effectively restored function and reversed cellular abnormalities in autophagy-deficient organoids.
- The study proposes that NMN's protective effects may be linked to its ability to rebalance NAD⁺ metabolism.
Clinical Implications
The findings suggest that targeting autophagy may provide new therapeutic strategies for managing dry eye disease. NMN and similar agents could be explored as potential treatments to enhance lacrimal gland function and alleviate symptoms in patients with DED.
Conclusion
This research underscores the significance of autophagy in lacrimal gland biology and opens avenues for future therapeutic interventions in dry eye disease. Further validation in clinical settings is necessary to translate these findings into practice.
Related Resources & Content
- Contact Lens Spectrum, ONLINE PHOTO DIAGNOSIS, 2021 -- Epiphora Secondary to Dacryolith Obstruction of the Canaliculi
- Contact Lens Spectrum, The History of Dry Eye Diagnosis and Management, 2000 -- The History of Dry Eye Diagnosis and Management
- Contact Lens Spectrum, FROM THE BLUE BOX, 2022 -- Dry eye treatment has evolved substantially over the past few decades.
- TFOS DEWS III: Executive Summary - ScienceDirect, 2025 -- TFOS DEWS III reports update definition, diagnostic minimums, and management algorithms.
- Comparative Efficacy of Platelet-Rich Plasma, Autologous Serum, and Artificial Tears in Dry Eye Disease: A Systematic Review and Meta-Analysis - PubMed, 2025 -- Systematic review on biologic tears.
- Autophagy is required for the development and functionality of lacrimal gland-like organoids - PubMed, 2025 -- Study on autophagy's role in lacrimal gland organoids.
- Contact Lens Spectrum — Reader's Forum
- TFOS DEWS III: Executive Summary - ScienceDirect
- Comparative Efficacy of Platelet-Rich Plasma, Autologous Serum, and Artificial Tears in Dry Eye Disease: A Systematic Review and Meta-Analysis - PubMed
- Autophagy is required for the development and functionality of lacrimal gland-like organoids - PubMed
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
